Literature DB >> 28971363

Recommendations for Selection and Characterization of Protein Biomarker Assay Calibrator Material.

Kyra J Cowan1, Lakshmi Amaravadi2, Mark J Cameron3, Damien Fink4, Darshana Jani5, Medha Kamat6, Lindsay King5, Robert J Neely7, Yan Ni8, Paul Rhyne9, Renee Riffon10, Yuda Zhu11.   

Abstract

As biomarkers continue to become an integral part of drug development and decision-making, there are increased expectations for reliable and quantitative assays. Protein biomarker assay results are directly influenced by the calibrator material. The selection of calibrator material presents many challenges that impact the relative accuracy and performance of the assay. There is an industry-wide challenge finding reliable and well-characterized calibrator material with good documentation. Several case studies are presented that demonstrate some of the challenges involved in selecting appropriate calibrators along with the resolutions that were ultimately applied. From these experiences, we present here a set of recommendations for selecting and characterizing calibrator material based on the intended purpose of the assay. Finally, we introduce a commutability approach, based on common clinical chemistry practices, which can be used to demonstrate inter-changeability with calibrator materials across multiple lots and technology platforms for all types of protein biomarker assays.

Keywords:  biomarker assays; calibrator; reference material

Mesh:

Substances:

Year:  2017        PMID: 28971363     DOI: 10.1208/s12248-017-0146-9

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  30 in total

1.  Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules.

Authors:  Binodh DeSilva; Wendell Smith; Russell Weiner; Marian Kelley; JoMarie Smolec; Ben Lee; Masood Khan; Richard Tacey; Howard Hill; Abbie Celniker
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

Review 2.  Fit-for-purpose biomarker method validation in anticancer drug development.

Authors:  Jeffrey Cummings; Tim H Ward; Caroline Dive
Journal:  Drug Discov Today       Date:  2010-08-11       Impact factor: 7.851

Review 3.  Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis.

Authors:  Jean W Lee; Michael Hall
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-11-18       Impact factor: 3.205

4.  Parallelism experiments in biomarker ligand-binding assays to assess immunological similarity.

Authors:  Lindsay E King
Journal:  Bioanalysis       Date:  2016-12       Impact factor: 2.681

5.  Ligand binding assay critical reagents and their stability: recommendations and best practices from the Global Bioanalysis Consortium Harmonization Team.

Authors:  Lindsay E King; Esme Farley; Mami Imazato; Jeannine Keefe; Masood Khan; Mark Ma; K Susanne Pihl; Priya Sriraman
Journal:  AAPS J       Date:  2014-04-01       Impact factor: 4.009

6.  Workshop Report: Crystal City VI-Bioanalytical Method Validation for Biomarkers.

Authors:  Mark E Arnold; Brian Booth; Lindsay King; Chad Ray
Journal:  AAPS J       Date:  2016-08-11       Impact factor: 4.009

7.  Method validation and measurement of biomarkers in nonclinical and clinical samples in drug development: a conference report.

Authors:  Jean W Lee; Russ S Weiner; Jeff M Sailstad; Ronald R Bowsher; Dean W Knuth; Peter J O'Brien; Jean L Fourcroy; Rakesh Dixit; Lini Pandite; Robert G Pietrusko; Holly D Soares; Valerie Quarmby; Ole L Vesterqvist; David M Potter; James L Witliff; Herbert A Fritche; Timothy O'Leary; Lorah Perlee; Sunil Kadam; John A Wagner
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

8.  Problems associated with determining protein concentration: a comparison of techniques for protein estimations.

Authors:  Matthew I Knight; Paul J Chambers
Journal:  Mol Biotechnol       Date:  2003-01       Impact factor: 2.695

Review 9.  Validation of analytic methods for biomarkers used in drug development.

Authors:  Cindy H Chau; Olivier Rixe; Howard McLeod; William D Figg
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

Review 10.  Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs.

Authors:  J Cummings; F Raynaud; L Jones; R Sugar; C Dive
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

View more
  2 in total

1.  Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a).

Authors:  Santica M Marcovina; Noémie Clouet-Foraison; Marlys L Koschinsky; Mark S Lowenthal; Allen Orquillas; Michael B Boffa; Andrew N Hoofnagle; Tomáš Vaisar
Journal:  Clin Chem       Date:  2021-03-01       Impact factor: 12.167

2.  Biological Matrix Supply Chain Shortages: More Matrices Are Now Rare-the Case for Surrogate Matrices.

Authors:  Evan A Dubiel; Heather Myler; Mark E Arnold; Patrick Bennett; Jeff Gatz; Elizabeth Groeber; Seema Gupta; Cheikh Kane; Fumin Li; William Mylott; Courtney Noah; Mark O'Dell; Eric Tewalt; Dominic Warrino; Andrew Vick
Journal:  AAPS J       Date:  2022-03-14       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.